ATE343398T1 - Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge - Google Patents

Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge

Info

Publication number
ATE343398T1
ATE343398T1 AT02747880T AT02747880T ATE343398T1 AT E343398 T1 ATE343398 T1 AT E343398T1 AT 02747880 T AT02747880 T AT 02747880T AT 02747880 T AT02747880 T AT 02747880T AT E343398 T1 ATE343398 T1 AT E343398T1
Authority
AT
Austria
Prior art keywords
eye
compositions
methods
hyperimmune reactions
treating
Prior art date
Application number
AT02747880T
Other languages
English (en)
Inventor
Simon Skurkovich
Boris Skurkovich
Original Assignee
Advanced Biotherapy Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Biotherapy Inc filed Critical Advanced Biotherapy Inc
Application granted granted Critical
Publication of ATE343398T1 publication Critical patent/ATE343398T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT02747880T 2001-06-05 2002-06-04 Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge ATE343398T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29589501P 2001-06-05 2001-06-05
US09/894,287 US6534059B2 (en) 2001-06-05 2001-06-28 Compositions and methods for treating hyperimmune response in the eye

Publications (1)

Publication Number Publication Date
ATE343398T1 true ATE343398T1 (de) 2006-11-15

Family

ID=26969391

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02747880T ATE343398T1 (de) 2001-06-05 2002-06-04 Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge

Country Status (8)

Country Link
US (2) US6534059B2 (de)
EP (1) EP1401496B1 (de)
JP (1) JP2004532885A (de)
AT (1) ATE343398T1 (de)
AU (1) AU2002318175B2 (de)
CA (1) CA2449488C (de)
DE (1) DE60215649D1 (de)
WO (1) WO2002098460A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US6709655B2 (en) 2001-02-28 2004-03-23 Instituto Bioclon, S.A. De C.V. Pharmaceutical composition of F(ab1)2 antibody fragments and a process for the preparation thereof
US6861056B2 (en) * 2001-06-05 2005-03-01 Advanced Biotherapy, Inc. Compositions and methods for treating hyperimmune response in the eye
US6534059B2 (en) * 2001-06-05 2003-03-18 Advanced Biotherapy, Inc. Compositions and methods for treating hyperimmune response in the eye
US6712976B2 (en) * 2001-09-13 2004-03-30 Abtech Industries, Inc. Dual-action decontamination system
US7335759B2 (en) 2002-12-02 2008-02-26 Universidad Nacional Autónoma de Méxica (UNAM) Recombinant immunogens for the generation of antivenoms to the venom of scorpions of the genus Centruroides
ES2339236T3 (es) * 2003-07-25 2010-05-18 Laboratorios Silanes, S.A. De C.V. Administracion de fragmentos de anticuerpo f(ab')2 anti-tnf-alfa.
EA013118B1 (ru) * 2005-01-27 2010-02-26 Новиммун С.А. Антитела против интерферона-гамма и способы их применения
WO2006102654A1 (en) * 2005-03-24 2006-09-28 Washington University Reduction of ophthamologic neovascularization
US7381802B2 (en) * 2005-04-15 2008-06-03 Universidad Nacional Autónoma De México (UNAM) Human antibodies that specifically recognize the toxin Cn2 from Centruroides noxius scorpion venom
CA2654565A1 (en) * 2006-06-12 2007-12-21 Therakine Limited Topical treatment for diseases of eye surface
CA2734185C (en) 2008-08-15 2017-02-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for using interferon gamma to absorb fluid from the subretinal space
US11091543B2 (en) 2015-05-07 2021-08-17 Swedish Orphan Biovitrum Ag Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications
BR112017023867A2 (pt) 2015-05-07 2018-07-24 Novimmune Sa métodos e composições para diagnóstico e tratamento de distúrbios em pacientes com níveis elevados de cxcl9 e outros biomarcadores

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704362A (en) 1977-11-08 1987-11-03 Genentech, Inc. Recombinant cloning vehicle microbial polypeptide expression
UA41863C2 (uk) 1985-10-25 2001-10-15 Займодженетікс Інк. Спосіб одержання гетерологічного поліпептиду в еукаріотичних мікроорганізмах
JPS63501765A (ja) 1985-11-01 1988-07-21 インタ−ナショナル、ジェネティック、エンジニアリング　インコ−ポレ−テッド 抗体遺伝子のモジュ−ル組立体、それにより産生された抗体及び用途
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB8905400D0 (en) * 1989-03-09 1989-04-19 Jonker Margreet Medicaments
AU2777092A (en) * 1991-10-04 1993-05-03 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Treatment of ocular inflammation by blockage of cell adhesion molecules
US5888511A (en) 1993-02-26 1999-03-30 Advanced Biotherapy Concepts, Inc. Treatment of autoimmune diseases, including AIDS
DE19535073C1 (de) * 1995-09-21 1997-02-20 Roland Dr Grosmann Verfahren zur künstlichen Inkubation von Hühnereiern
US6534059B2 (en) * 2001-06-05 2003-03-18 Advanced Biotherapy, Inc. Compositions and methods for treating hyperimmune response in the eye
US6861056B2 (en) * 2001-06-05 2005-03-01 Advanced Biotherapy, Inc. Compositions and methods for treating hyperimmune response in the eye

Also Published As

Publication number Publication date
US7232568B2 (en) 2007-06-19
HK1063601A1 (en) 2005-01-07
DE60215649D1 (de) 2006-12-07
JP2004532885A (ja) 2004-10-28
EP1401496A1 (de) 2004-03-31
EP1401496B1 (de) 2006-10-25
WO2002098460A1 (en) 2002-12-12
CA2449488A1 (en) 2002-12-12
US6534059B2 (en) 2003-03-18
US20020182212A1 (en) 2002-12-05
CA2449488C (en) 2010-02-09
EP1401496A4 (de) 2005-08-31
US20030224005A1 (en) 2003-12-04
AU2002318175B2 (en) 2006-01-05

Similar Documents

Publication Publication Date Title
DE60215649D1 (de) Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge
IL148079A0 (en) Human ctla-4 antibodies and compositions containing the same
ATE448775T1 (de) Rifalazil zur behandlung von infektionen mit clostridium difficile
IL169152A0 (en) Antibodies against pd-1 and uses therefor
DE69935133D1 (de) Antagoniste zur behandlung von cd11/cd18 adhäsionsrezeptor-vermittelten krankheiten
BG110703A (en) PHARMACEUTICAL COMPOSITION, INCLUDING HUMAN ANTIBODIES CONNECTING HUMAN TNF ALPHA AND HIS APPLICATION
DE60335552D1 (de) Neue zusammensetzung und verfahren zur behandlung von immunerkrankungen
WO2005059106A3 (en) Interferon alpha antibodies and their uses
BR0008688A (pt) Antagonistas de il-18 recombinantes utilizáveis no tratamento de distúrbios mediados por il-18
DE60229059D1 (de) Proteomimetische verbindungen und verfahren
WO2004047728A3 (en) Compositions and methods for the treatment of immune related diseases
WO2004039956A3 (en) Compositions and methods for the treatment of immune related diseases
EP1064308A4 (de) Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen
DE60034871D1 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
DE69325393D1 (de) Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungen
DE602004021847D1 (de) Verfahren zur prävention und behandlung von diabetes mit neurturin
ATE346867T1 (de) Rekombinante il-5 antagonisten für die behandlung von il-5 bedingten krankheiten
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
ATE360442T1 (de) Verfahren und zusammensetzungen zur behandlung von hyperproliferativen zuständen
DE60035693D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
ATE196083T1 (de) Verwendung von ferrioxamin-b zur behandlung septischen schocks
ATE423110T1 (de) Verbindungen, zusammensetzungen und verfahren zur behandlung von zellulären proliferativen erkrankungen
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
WO2004083382A3 (en) Compositions and methods for treating hyperimmune response in the eye
ATE313561T1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties